Zendy
Open Access
High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller
Journal Of Clinical OncologyPeer ReviewedAna M. González-Angulo +192009Journals
To evaluate the risk of recurrence in women diagnosed with T1a and T1b, node-negative, human epidermal growth factor receptor 2 (HER2) -positive breast cancer.

The content you want is available to Zendy users.

Already have an account? Sign in
Having issues? Contact support